Under this contract, Daré will work to identify and assess for-profit and non-profit organizations worldwide with demonstrated capabilities in formulation development, clinical and commercial manufacturing, clinical trial design, and regulatory support for contraceptive products.
"We are honored to be selected to receive funding from the Gates Foundation to help strengthen the global contraceptive innovation ecosystem," said Sabrina Martucci Johnson, President and CEO of Daré Bioscience. "Daré's mission is to close critical gaps in care using rigorous science and technologies that serve her needs. This initiative will help identify potential strategic partners for the foundation that can help to accelerate the translation of new contraceptive concepts into products that make a meaningful difference globally."
"This initiative builds on Daré's expertise in women's health product development and its track record of working with public and private sector collaborators to advance innovative contraceptive and reproductive health solutions," added Johnson.
About Daré Bioscience
Daré Bioscience is a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions. Every innovation Daré advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, pelvic pain to fertility, vaginal health to infectious disease, Daré is working to close critical gaps in care using science that serves her needs.
For decades, women have been told to "wait it out" or "live with it," while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to real, evidence-based solutions continues to lag. Daré was founded to change that. As a female-led health biotech company, Daré is accelerating the development of credible, science-based solutions that meet the high standards of clinical rigor, randomized, controlled ...
